Anaesthetic considerations in progressive familial intrahepatic cholestasis (Byler’s disease)
✍ Scribed by Gerhard Müller; Francis Veyckemans; Marianne Carlier; Luc J. Van Obbergh; Marc De Kock; Etienne M. Sokal; Jean-Bernard Otte
- Publisher
- Springer-Verlag
- Year
- 1995
- Tongue
- French
- Weight
- 706 KB
- Volume
- 42
- Category
- Article
- ISSN
- 1496-8975
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
have recently provided support for the heterogeneity of this Progressive familial intrahepatic cholestasis (PFIC) is clinical entity, suggesting different causes: clinical, biochemia lethal inherited childhood cholestasis of hepatocellucal, and liver histological features suggest at least two subcat
We studied histological features and long-term outcomes in patients with progressive familial intrahepatic cholestasis type 1 (PFIC1) after liver transplantation (LT). Histological findings were correlated with the post-LT course and treatment in 11 recipients with PFIC1. Ages at LT varied from 1 to
Disruption of the murine mdr2 (multidrug-resistance) disease, characterized by a portal inflammation and a gene, which encodes a phosphatidylcholine flippase, ductular proliferation, is probably the consequence of leads to a hepatic disorder because of loss of biliary a toxic effect of bile acids on